Novo Nordisk A/S (NYSE:NVO) Receives $135.00 Average Target Price from Analysts
Novo Nordisk A/S (NYSE:NVO – Get Free Report) has been given a consensus recommendation of “Hold” by the ten analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and five have given a buy recommendation to the company. […]
Novo Nordisk A/S (NYSE:NVO – Get Free Report) has been given a consensus recommendation of “Hold” by the ten analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and five have given a buy recommendation to the company. […]
